214 related articles for article (PubMed ID: 38018574)
1. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
[TBL] [Abstract][Full Text] [Related]
4.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis.
Sakamoto Y; Mima K; Ishimoto T; Ogata Y; Imai K; Miyamoto Y; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Komohara Y; Ogino S; Baba H
Cancer Sci; 2021 Nov; 112(11):4470-4477. PubMed ID: 34464993
[TBL] [Abstract][Full Text] [Related]
6. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
[TBL] [Abstract][Full Text] [Related]
8. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
10. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
[TBL] [Abstract][Full Text] [Related]
11.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
12. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis.
Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X
Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
15.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
16. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
17. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
18. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
